🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · Real-Time Price · USD
13.26
-0.08 (-0.60%)
Nov 20, 2026, 12:47 PM EST - Market open

ADMA Biologics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
124.5687.63103.1551.3586.5251.09
Cash & Short-Term Investments
124.5687.63103.1551.3586.5251.09
Cash Growth
102.91%-15.04%100.86%-40.65%69.36%-8.64%
Receivables
169.22158.435027.4215.5128.58
Inventory
266.12206.47170.24172.91163.28124.72
Prepaid Expenses
15.977.468.035.335.14.34
Other Current Assets
-6.53----
Total Current Assets
575.86466.51331.41257.01270.4208.73
Property, Plant & Equipment
72.6471.7163.3463.4768.7558.2
Goodwill
3.533.533.533.533.533.53
Other Intangible Assets
0.580.630.460.51.011.73
Long-Term Deferred Tax Assets
70.6973.2684.28---
Other Long-Term Assets
9.188.65.664.674.774.07
Total Assets
732.49624.24488.68329.18348.46276.25

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
35.6622.5220.2215.6613.2312.43
Accrued Expenses
33.2627.6828.6330.5523.1916.23
Current Portion of Long-Term Debt
4.222.81----
Current Portion of Leases
1.181.11.221.050.910.59
Current Income Taxes Payable
15.68.623.48---
Current Unearned Revenue
---0.180.140.14
Other Current Liabilities
5.366.8222.371.80.98
Total Current Liabilities
95.2869.5455.5449.8139.2730.38
Long-Term Debt
191.6469.3372.34130.59142.8394.87
Long-Term Leases
5.776.658.569.7810.77.46
Long-Term Unearned Revenue
1.31.411.551.691.831.98
Other Long-Term Liabilities
--1.672.111.850.4
Total Liabilities
293.98146.92139.66193.98196.49135.08

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.020.020.020.020.020.02
Additional Paid-In Capital
680.84671.04657.58641.44629.97553.27
Retained Earnings
-28.62-161.65-308.58-506.26-478.02-412.11
Treasury Stock
-213.74-32.09----
Shareholders' Equity
438.51477.32349.02135.21151.97141.17
Total Liabilities & Equity
732.49624.24488.68329.18348.46276.25

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
202.879.8982.12141.42154.44102.92
Net Cash (Debt)
-78.257.7521.03-90.07-67.92-51.83
Net Cash Growth
--63.17%----
Net Cash Per Share
-0.330.030.09-0.40-0.34-0.37
Filing Date Shares Outstanding
221.85238.16237.62228.22222.16195.92
Total Common Shares Outstanding
222.79237.87236.62226.06221.82195.81
Working Capital
480.59396.97275.87207.21231.14178.35
Book Value Per Share
1.972.011.480.600.690.72
Tangible Book Value
434.4473.16345.03131.18147.43135.91
Tangible Book Value Per Share
1.951.991.460.580.660.69
Land
13.0413.044.344.344.344.34
Buildings
28.2326.8921.7920.2219.5419.07
Machinery
42.5140.0432.9232.9329.224.17
Construction In Progress
11.378.468.152.276.735.5
Leasehold Improvements
15.0614.9821.0720.8117.9311.13
SEC Filings: 10-K · 10-Q